[Anderson's disease/chylomicron retention disease].
Ohashi
K
K
Department of Metabolic Diseases, Faculty of Medicine, University of Tokyo.
D000818:Animals; D053299:Apolipoprotein B-100; D053283:Apolipoprotein B-48; D001055:Apolipoproteins B / Q000097:blood / Q000172:deficiency; D002914:Chylomicrons / Q000378:metabolism*; D003937:Diagnosis, Differential; D018752:Diet, Fat-Restricted; D006801:Humans; D006995:Hypobetalipoproteinemias / Q000209:etiology / Q000503:physiopathology; D011379:Prognosis; D014801:Vitamin A / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D053299:Apolipoprotein B-100; D053283:Apolipoprotein B-48; D001055:Apolipoproteins B; D002914:Chylomicrons; D014801:Vitamin A; D014810:Vitamin E